Crinetics Pharmaceuticals

Crinetics Pharmaceuticals

Yahoo Finance • 18 days ago

High-flyer healthcare stocks: Ten names with strong momentum, weak valuations

[Heart Health Concept] Eoneren/E+ via Getty Images Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price veloci... Full story

Yahoo Finance • 21 days ago

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger—CRNX, PSBQ, D, and NEE

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story

Yahoo Finance • 25 days ago

Crinetics Pharmaceuticals GAAP EPS of -$1.14 beats by $0.07, revenue of $25.12M beats by $10.25M

* Crinetics Pharmaceuticals press release [https://seekingalpha.com/pr/20604770-crinetics-pharmaceuticals-reports-second-quarter-2026-financial-results-and-provides-business] (CRNX [https://seekingalpha.com/symbol/CRNX]): Q2 GAAP EPS of... Full story

Yahoo Finance • last month

Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE, July 21, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Crinetics (Nasdaq: CRNX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Vertex. Click here to learn... Full story

Yahoo Finance • last month

Catalyst watch: Farnborough Air Show, Tesla earnings, AMD AI event, and Samsung reveals

[Skyline of Lower Manhattan] Art Wager Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - JULY 20... Full story

Yahoo Finance • last month

Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH?

The iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) offers heavy exposure to pharmaceutical giants and a higher yield, while the State Street SPDR S&P Pharmaceuticals ETF (NYSEMKT:XPH) provides broader, more equal-weighted exposure. Both f... Full story

Yahoo Finance • last month

Halper Sadeh LLC is Investigating Whether ESI, CRNX, SOLS are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • last month

Vertex to Acquire Crinetics Pharmaceuticals (CRNX) in $85 Per Share Cash Deal

Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the 10 affordable biotech stocks to buy right now. On July 6, Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) and Vertex Pharmaceuticals announced that both companies have agreed to a de... Full story

Yahoo Finance • last month

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TriCo Bancshares (Nasdaq – TCBK), Twin Vee PowerCats Co. (Nasdaq -VEEE), Crinetics Pharmaceuticals, Inc. (Nasdaq – CRNX), Element Solutions Inc. (NYSE – ESI)

BALA CYNWYD, Pa., July 14, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • last month

Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals

When a company acquires another business, there's often going to be a premium involved, especially if it's in good shape or has some promising assets in its portfolio. But normally, you don't see a company pay double what its current valua... Full story

Yahoo Finance • 2 months ago

Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse

Key Points Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better. Vertex Pharmaceuticals agreed to buy Crinetics Pharmaceuticals for $85 per share in cash, valuing the deal at about $10 billion equity valu... Full story

Yahoo Finance • 2 months ago

Key deals this week: MGM, PERF, VRTX, and more

[M A - concept waiting for mergers and acquisitions.3D rendering on yellow background.] fengdr Here's a list of key deals reported across sectors this week: * MGM Resorts (MGM [https://seekingalpha.com/symbol/MGM]) has reportedly start... Full story

Yahoo Finance • 2 months ago

Catalyst Watch: Bank earnings, Netflix results, Alzheimer's conference

[NETFLIX corporate office building with signage on top, located at 1341 Vine Street, Los Angeles] Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events... Full story

Yahoo Finance • 2 months ago

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?

Key Points Vertex Pharmaceuticals is the global leader in cystic fibrosis treatments, and this has translated into billion-dollar earnings. The biotech has taken key steps in recent years to expand into other treatment areas, and efforts... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC is Investigating Whether CRNX, ESI, INVE, SLP are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 2 months ago

Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?

We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is one of the best healthcare stocks on our list. TheFly reported on July 2 that UBS analyst Ashwani Verma i... Full story

Yahoo Finance • 2 months ago

Viking Therapeutics (VKTX) Draws Takeover Focus After Vertex's $10 Billion Crinetics Deal

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals for about US$10b, reigniting takeover speculation across the ob... Full story

Yahoo Finance • 2 months ago

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

Key Points Crinetics' Palsonify was FDA-approved late last year. The company's atumelnant is currently in late Phase 3 clinical testing.10 stocks we like better than Vertex Pharmaceuticals › In the latest big-ticket deal in the pharmaceu... Full story

Yahoo Finance • 2 months ago

Eli Lilly price target boost, Vertex-Crinetics deal, Meta's new social media lawsuit

Market Domination Host Josh Lipton tracks several of the day's top trending stock tickers, including JPMorgan analysts raising their price target on Eli Lilly (LLY) stock, Vertex Pharmaceuticals' (VRTX) acquisition of Crinetics (CRNX), and... Full story

Yahoo Finance • 2 months ago

Stock Indexes Falter as Chip Stocks Tumble

The S&P 500 Index ($SPX) (SPY) today is down -0.67%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.38%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -2.14%.  September E-mini S&P futures (ESU26) are down -0.68%, and September... Full story